Patents by Inventor Christopher McMahon

Christopher McMahon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOPAMINERGIC PRECURSOR CELLS AND METHODS OF USE
    Publication number: 20240219375
    Abstract: Midbrain dopaminergic neuronal precursor cells that can be used to treat a brain disorder are provided herein. Improved mono-SMAD methods are provided that can be used to differentiate pluripotent cells into midbrain dopaminergic (DA) neurons or midbrain neuronal precursors. In some aspects, methods are provided for mono-SMAD culture protocols and culture durations that can be used to generate dopaminergic neuronal precursor cells that have significantly improved properties for the treatment of a brain disorder such as, e.g., Parkinson's disease. Methods of treating Parkinson's disease and other brain diseases with the midbrain dopaminergic neuronal precursor cells are also provided.
    Type: Application
    Filed: April 7, 2022
    Publication date: July 4, 2024
    Applicant: FUJIFILM Cellular Dynamics, Inc.
    Inventors: Christopher McMAHON, Randall LEARISH, Carrie CHAVEZ, Cayla THOMPSON
  • A Composition And Method For Improving The Profile Of Blood
    Publication number: 20220280605
    Abstract: Use of a peptide or fragment thereof comprising SEQ ID NO. 1, or a peptide or fragment having at least 80% sequence identity thereto, in the manufacture of a medicament for one or more of reducing triglycerides, reducing LDL, reducing sdLDL, reducing glucose, reducing insulin, reducing HbA1c and increasing insulin sensitivity.
    Type: Application
    Filed: April 29, 2020
    Publication date: September 8, 2022
    Inventors: Denis Watson, Christopher McMahon, Blake Paget, David Norrie, Kim Whiteman, Frank Sieg